| Literature DB >> 36267888 |
Minjie Bian1, Yuxian Shen1, Yijie Huang1, Lishan Wu1, Yueyan Wang1, Suyue He1, Dongfeng Huang1,2, Yurong Mao1,2.
Abstract
Introduction: This study was conducted to evaluate whether a non-immersive virtual reality (VR)-based intervention can enhance lower extremity movement in patients with cerebral infarction and whether it has greater short-term and long-term effectiveness than conventional therapies (CTs). Materials and methods: This was a single-blinded, randomized clinical controlled trial. Forty-four patients with subacute cerebral infarction were randomly allocated to the VR or CT group. All intervention sessions were delivered in the inpatient unit for 3 weeks. Outcomes were measured before (baseline) and after the interventions and at 3-month, 6-month and 1-year follow-ups. The outcomes included clinical assessments of movement and balance function using the Fugl-Meyer Assessment of Lower Extremity (FMA-LE) and Berg Balance Scale (BBS), and gait parameters in the sagittal plane.Entities:
Keywords: gait analysis; ischemic stroke; motor activity; rehabilitation; virtual reality
Year: 2022 PMID: 36267888 PMCID: PMC9577285 DOI: 10.3389/fneur.2022.985700
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.086
Figure 1Examples of VR interventions. (a) Wii exergame training; (b) an active and passive trainer with a VR screen; (c) a VR balance training system; (d) lower extremity training in a VR gait training system.
VR training systems applied in the study.
|
|
|
|
|---|---|---|
| Wii exergame training system | Camera | Balance training (dynamic) |
| An active and passive trainer with a VR screen | Sensors (speed and moment) | Cycling |
| A VR balance training system | Pressure transducers | Balance training (standing) |
| A VR gait training system | Sensors (speed and direction) | Walking, stepping and lower extremity training |
Figure 2Three-dimensional data capture.
Demographic characteristics (Mean ± SD) at baseline for three groups.
|
|
|
|
| |
|---|---|---|---|---|
| Age | 58.17 ± 8.12 | 53.25 ± 8.72 | 55.00 ± 10.27 | 0.599 |
| Gender (male/female) | 6/6 | 14/4 | 13/3 | 0.803 |
| Affected side (right/left) | 10/8 | 6/10 | 0.292 | |
| NIHSS | 4.69 ± 2.50 | 4.56 ± 2.854 | 0.888 | |
| MMSE | 28.56 ± 1.83 | 28.06 ± 1.73 | 0.412 | |
| BBS | 36.94 ± 10.55 | 38.28 ± 14.05 | 0.758 | |
| FMA-LE | 23.10 ± 5.89 | 23.50 ± 4.46 | 0.834 | |
| Walking speed | 0.42 ± 0.20 | 0.43 ± 0.21 | 0.812 |
MMSE, Mini Mental State Examination; NIHSS, National Institute of Health Stroke Scale; BBS, Berg Balance Scale; FMA-LE, Fugl-Meyer Assessment-Lower Extremity.
Balance and lower motor function results of pre, post and follow-ups between CT and VR group.
|
|
|
| ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| |||||||
| BBS | 36.94 ± 10.55 | 38.38 ± 8.72* | 48.88 ± 5.74* | 52.00 ± 4.66* | 53.00 ± 3.74* | 38.28 ± 14.05 | 35.86 ± 13.15* | 43.00 ± 10.47* | 44.71 ± 11.25* | 47.00 ± 10.42* |
| FMA-LE | 23.10 ± 5.89 | 21.63 ± 5.55* | 25.88 ± 5.06* | 27.13 ± 4.29* | 27.50 ± 4.07* | 23.50 ± 4.46 | 23.00 ± 5.35 | 24.14 ± 5.93* | 25.43 ± 5.26* | 25.71 ± 4.92* |
*Significant difference between pre and follow-ups of intervention (P <0.05).
Spatiotemporal results of pre, post and follow-up among three groups.
|
|
|
|
| ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
| ||
| Walking speed | 0.96 ± 0.13 | 0.42 ± 0.21 | 0.52 ± 0.24* | 0.65 ± 0.28* | 0.65 ± 0.27* | 0.73 ± 0.24* | 0.43 ± 0.21 | 0.50 ± 0.24 | 0.55 ± 0.28 | 0.57 ± 0.24 | 0.62 ± 0.23 |
| Cadence | 108.13 ± 10.65 | 74.63 ± 16.06 | 79.35 ± 18.16* | 87.78 ± 16.34* | 88.05 ± 13.01* | 93.36 ± 14.53* | 72.62 ± 24.12 | 77.21 ± 27.67 | 77.07 ± 22.40 | 77.78 ± 20.05 | 82.09 ± 17.52 |
| Stride time | 1.12 ± 0.11 | 1.70 ± 0.43 | 1.62 ± 0.42 | 1.42 ± 0.28* | 1.40 ± 0.21 | 1.32 ± 0.22* | 1.84 ± 0.63 | 1.76 ± 0.65 | 1.70 ± 0.55 | 1.66 ± 0.49 | 1.56 ± 0.48 |
| Opposite foot off | 11.14 ± 1.35 | 15.88 ± 4.93 | 15.61 ± 7.25 | 12.52 ± 4.97 | 12.68 ± 3.35 | 12.61 ± 3.04 | 18.60 ± 12.00 | 18.91 ± 0.80 | 16.49 ± 10.53 | 15.46 ± 9.07 | 20.34 ± 20.41 |
| Opposite foot contact | 49.60 ± 1.36 | 44.57 ± 6.07 | 47.21 ± 5.39 | 47.63 ± 3.65 | 49.28 ± 5.48* | 46.70 ± 3.34 | 45.94 ± 6.12 | 45.65 ± 4.72 | 48.96 ± 6.38 | 46.62 ± 6.95 | 45.41 ± 7.78 |
| Step time | 0.56 ± 0.06 | 0.95 ± 0.30 | 0.86 ± 0.25* | 0.75 ± 0.17* | 0.71 ± 0.14* | 0.71 ± 0.15* | 1.01 ± 0.41 | 0.98 ± 0.43 | 0.86 ± 0.26 | 0.90 ± 0.35 | 0.87 ± 0.37 |
| Single support | 0.43 ± 0.04 | 0.47 ± 0.11 | 0.49 ± 0.09 | 0.49 ± 0.09 | 0.51 ± 0.10 | 0.44 ± 0.06 | 0.50 ± 0.08 | 0.44 ± 0.14 | 0.52 ± 0.10 | 0.49 ± 0.07 | 0.37 ± 0.35 |
| Double support | 0.25 ± 0.04 | 0.61 ± 0.29 | 0.54 ± 0.31 | 0.38 ± 0.19* | 0.37 ± 0.12* | 0.38 ± 0.16* | 0.67 ± 0.50 | 0.73 ± 0.50 | 0.57 ± 0.42 | 0.55 ± 0.35 | 0.58 ± 0.42 |
| Foot off | 60.82 ± 1.90 | 63.54 ± 5.80 | 63.29 ± 6.09 | 61.25 ± 4.57 | 62.78 ± 5.29 | 62.27 ± 4.27 | 62.63 ± 7.71 | 65.45 ± 6.38 | 62.78 ± 5.20 | 62.18 ± 5.04 | 61.00 ± 5.53 |
| Stride length | 1.06 ± 0.11 | 0.65 ± 0.20 | 0.76 ± 0.21* | 0.85 ± 0.25* | 0.87 ± 0.28* | 0.93 ± 0.20* | 0.69 ± 0.20 | 0.75 ± 0.22 | 0.81 ± 0.28 | 0.84 ± 0.23 | 0.88 ± 0.22 |
| Step length | 0.54 ± 0.07 | 0.33 ± 0.11 | 0.38 ± 0.11 | 0.44 ± 0.11* | 0.44 ± 0.13* | 0.48 ± 0.10* | 0.38 ± 0.11 | 0.38 ± 0.11 | 0.43 ± 0.11 | 0.43 ± 0.12 | 0.46 ± 0.11 |
*Significant difference between pre and follow-ups of intervention (P <0.05).
Kinematic results in the sagittal plane of pre, post and follow-up among three groups.
|
|
|
|
| ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
| ||
| Hip-max | 30.20 ± 7.85 | 20.85 ± 7.02 | 24.80 ± 6.18 | 21.26 ± 11.17 | 24.82 ± 10.43 | 20.91 ± 10.07 | 20.94 ± 8.77 | 21.90 ± 9.57 | 19.55 ± 10.39 | 21.08 ± 9.81 | 22.14 ± 9.88 |
| Knee-max | 57.28 ± 10.36 | 29.82 ± 16.14 | 36.04 ± 14.62 | 38.07 ± 14.63 | 43.87 ± 21.34* | 44.43 ± 21.62 | 32.67 ± 15.61 | 36.50 ± 17.08 | 31.85 ± 16.30 | 31.66 ± 18.29 | 37.84 ± 18.75 |
| Ankle-max | 9.84 ± 7.14 | 13.41 ± 3.82 | 13.61 ± 6.03 | 12.91 ± 8.67 | 13.77 ± 2.11 | 11.36 ± 3.66 | 11.95 ± 7.82 | 12.11 ± 6.51 | 12.74 ± 6.56 | 9.82 ± 3.91 | 12.77 ± 4.21 |
| Hip-min | −8.56 ± 7.49 | −7.21 ± 9.79 | −6.75 ± 11.51 | −11.09 ± 16.51 | −8.53 ± 12.72 | −13.51 ± 1.25 | −6.75 ± 9.91 | −8.65 ± 13.23 | −11.37 ± 8.68 | −9.29 ± 9.95 | −10.04 ± 7.72 |
| Knee-min | 5.63 ± 4.67 | 2.65 ± 7.53 | 4.00 ± 7.77 | 0.83 ± 9.09 | 2.90 ± 5.56 | 0.75 ± 6.14 | −0.71 ± 8.81 | 0.53 ± 8.64 | −1.31 ± 1.71 | −3.24 ± 7.39 | −1.88 ± 7.58 |
| Ankle-min | −16.47 ± 7.21 | −5.36 ± 5.93 | −6.91 ± 8.80 | −6.28 ± 8.49 | −4.63 ± 5.63 | −8.84 ± 5.85 | −9.67 ± 7.96 | −8.19 ± 6.73 | −10.22 ± 5.02 | −9.49 ± 5.11 | −8.75 ± 6.10 |
| Hip-range | 38.76 ± 3.68 | 28.05 ± 8.68 | 31.56 ± 10.95 | 32.35 ± 8.89 | 33.35 ± 11.28 | 34.42 ± 7.4 | 27.69 ± 8.10 | 30.55 ± 8.98 | 30.92 ± 10.83 | 30.37 ± 11.61 | 32.18 ± 10.57 |
| Knee-range | 51.65 ± 8.45 | 27.17 ± 14.48 | 32.05 ± 15.20 | 37.24 ± 16.82 | 40.97 ± 20.46 | 43.68 ± 18.82 | 33.38 ± 12.33 | 35.96 ± 14.06 | 33.15 ± 14.74 | 34.91 ± 6.98 | 39.72 ± 16.71 |
| Ankle-range | 26.30 ± 5.84 | 18.77 ± 6.59 | 20.52 ± 7.39 | 19.19 ± 5.02 | 18.40 ± 6.30 | 20.20 ± 6.75 | 21.62 ± 9.07 | 20.30 ± 6.23 | 22.96 ± 6.95 | 19.31 ± 3.13 | 21.52 ± 4.57 |
*Significant difference between pre and follow-ups of intervention (P <0.05).
Figure 3Mean hip, knee, and ankle joint kinematic curve for all participants in the sagittal plane of both groups during pre-, post-training and follow-up (compared with normal gait cycles).